Suchergebnisse - (Person:"Wang, Yeming")

PubPharm (183)

51

Receptor inhibitor, pharmaceutical composition comprising same, and use thereof

enthalten in: Europäisches Patentamt | 2022

von ZHAO YANPING | WANG HONGJUN | WANG YEMING | +8

52

Health outcomes in people 2 years after surviving hospitalisation with COVID-19 : a longitudinal cohort study

enthalten in: The Lancet. Respiratory medicine | 2022

von Huang, L. | Li, X. | Gu, X. | +13

CommentIn: Lancet Respir Med. 2022 Sep;10(9):e82. - PMID 35697052

53

Evaluation of the Efficacy and Safety of Intravenous Remdesivir in Adult Patients with Severe Pneumonia caused by COVID-19 virus Infection: study protocol for a Phase 3 Randomized, Double-blind, Placebo-controlled, Multicentre trial

enthalten in: ResearchSquare.com | 2022

von Wang, Y. | Zhou, F. | Zhang, D. | +22

54

The Characteristics of Laboratory Tests at Admission and the Risk Factors for Adverse Clinical Outcomes of Severe and Critical COVID-19

enthalten in: ResearchSquare.com | 2022

von Wang, L. | Cheng, X. | Dong, Q. | +12

55

The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients

enthalten in: ResearchSquare.com | 2022

von Wang, L. | Cheng, X. | Dong, Q. | +12

56

Evaluation of the Efficacy and Safety of Intravenous Remdesivir in Adult Patients with Severe Pneumonia caused by COVID-19 virus Infection: study protocol for a Phase 3 Randomized, Double-blind, Placebo-controlled, Multicentre trial

enthalten in: ResearchSquare.com | 2022

von Horby, P. | Cao, B. | Wang, Y. | +1

57

Rheumatic Symptoms Following Coronavirus Disease 2019 (COVID-19) : A Chronic Post-COVID-19 Condition

enthalten in: Open forum infectious diseases | 2022

von Cui, D. | Wang, Y. | Huang, L. | +5

58

SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19 : a longitudinal cohort study

enthalten in: The Lancet. Microbe | 2022

von Guo, L. | Wang, G. | Wang, Y. | +17

59

Compound for inhibiting and inducing degradation of EGFR and ALK

enthalten in: Europäisches Patentamt | 2022

von ZHAO YANPING | WANG HONGJUN | WANG YEMING | +9

60

Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19 : A cohort study

enthalten in: EBioMedicine | 2022

von Gu, X. | Huang, L. | Cui, D. | +6